Arcus Biosciences RCUS Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's common stock, par value (in dollars per share)?
- Arcus Biosciences (RCUS) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Arcus Biosciences's common stock, par value (in dollars per share) changed year-over-year?
- Arcus Biosciences's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Arcus Biosciences's common stock, par value (in dollars per share)?
- Over 3 years (2022 to 2025), Arcus Biosciences's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.